Drug touted by Trump as COVID-19 treatment tied to increased risk of death: study

US

FILE PHOTO: A nurse shows a Hydroxychloroquine pill, amid the coronavirus disease (COVID-19) outbreak, at Nossa Senhora da Conceicao hospital in Porto Alegre, Brazil, April 23, 2020. REUTERS/Diego Vara

(Reuters) – Malaria drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking, was tied to increased risk of death in a study in 96,000 COVID-19 patients, according to a paper published in the Lancet.

The study found here that people treated with hydroxychloroquine, or the closely related drug chloroquine, had higher risk of in-hospital death when compared to those who had not been given the drug.

Reporting by Manas Mishra in Bengaluru; Editing by Saumyadeb Chakrabarty

Products You May Like

Articles You May Like

Prepare to study in Canada
Study permit: Who can apply
Canada’s Parents and Grandparents Immigration Hit New Record In 2023
Canada’s Start-Up Visa: How Much Money Do I Need?
Former Wards Of Protective Care In Canada Get Permanent Residence Pathway
Let In More Construction Trades Helpers, Business Groups Tell IRCC
Canada Saw Surge In Spousal Immigration In 2023

Leave a Reply

Your email address will not be published. Required fields are marked *